Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,730 | -7,200 | -9,890 | -4,090 | -8,610 |
| Depreciation Amortization | 380 | 400 | 200 | 30 | 150 |
| Other Working Capital | -230 | -70 | 8 | 490 | 2,320 |
| Other Operating Activity | 670 | 2,020 | 3,082 | 1,210 | 320 |
| Operating Cash Flow | $-2,910 | $-4,850 | $-6,600 | $-2,360 | $-5,820 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 20 | 110 | -1,960 | -40 | -30 |
| Net Acquisitions | -190 | 0 | 0 | -660 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -10 | -150 |
| Investing Cash Flow | $-170 | $110 | $-1,960 | $-710 | $-180 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -50 | -890 | 7,870 | 14,110 | 5,470 |
| Financing Cash Flow | $-50 | $-890 | $7,870 | $14,110 | $5,470 |
| Beginning Cash Position | 5,850 | 11,490 | 12,190 | 1,150 | 850 |
| End Cash Position | 2,710 | 5,850 | 11,490 | 12,190 | 320 |
| Net Cash Flow | $-3,140 | $-5,630 | $-700 | $11,030 | $-530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,910 | -4,850 | -6,600 | -2,360 | -5,820 |
| Free Cash Flow | -2,910 | -4,850 | -6,600 | -2,360 | -5,820 |